The future liver remnant in patients undergoing the Associating Liver Partition with Portal Vein Ligation for Staged hepatectomy (ALPPS) maintains the immunological components of a healthy organ.

The future liver remnant in patients undergoing the Associating Liver Partition with Portal Vein Ligation for Staged hepatectomy (ALPPS) maintains the immunological components of a healthy organ.

Background and Aims: A short-interval, two-stage approach termed associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) increases the number of patients with extensive malignant disease of the liver and a small future liver remnant (FLR) that can undergo liver resection....

Full description

Bibliographic Details
Main Authors: Ram Venkatesh Anantha, Christopher Ryan Shaler, Courtney Erin Meilleur, Jeremy Parfitt, S.M. Mansour Haeryfar, Roberto Hernandez-Alejandro
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Medicine
Subjects:
Flow Cytometry
Hepatectomy
Immunophenotyping
Liver Regeneration
liver metastases
ALPPS
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmed.2016.00032/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fmed.2016.00032/full

Similar Items